title: Simulated application of US cardiology guidelines for statin use to hospital patients in Turkey.
abstract: OBJECTIVE
  Simulate the application of the new cardiology prevention guideline on statin use in an angiography clinic sample taken from a hospital in Turkey.
  
  
  METHODS
  Taking statins was used as a quality indicator. All cases (323) included in the sample met criteria for taking statins upon arrival in the angiography clinic. The study population was divided into 3 groups: critical coronary artery disease (CAD) (>50%), noncritical (<50%), or individuals with normal coronary arteries. Patient risk factors were tested for association with taking statins using multiple logistic regression analysis.
  
  
  RESULTS
  Only 20.2% of patients were taking statins when they were accepted for coronary angiography. Patients with critical CAD and noncritical CAD had higher odds of receiving statins than persons with no CAD [odds ratio (OR)=12.9, P<.001 and OR=3.5, P=.025, respectively]. Patients receiving angiographic interventions for stent control were more likely to be on statins than patients with angina (OR=5.298, P=0.004). Compared to those not taking the treadmill test, both those with positive and those with negative results had reduced odds of receiving statins (OR=0.260, P=.002, and OR=0.130, P=.002, respectively). Both former and current smokers had lower odds of receiving statins than persons who had never smoked (OR=0.148, P<.001, and OR=0.161, P=.001). Patients taking aspirin were at risk of not being on statins (OR=0.238, P = .001).
  
  
  CONCLUSIONS
  Most of the patients in this study were not taking statins comparing according to US guidelines. Patients who exhibited risk factors for a cardiovascular event but who had not been diagnosed with CAD were at risk for not being on statins.
authors: Department of Family Medicine, Mayo Clinic, Rochester, Minnesota (Drs Rohrer and Agerter); Department of Family Medicine, Turkish Military Academy Primary Care Examination Center, Ankara, Turkey (Dr Doganer); and Gulhane Military Medical Faculty, General Dr Tevfik Saglam Caddesi, Etlik, Ankara, Turkey (Drs Aydogan and Barcin).
authors: James E
authors: JE
authors: Rohrer
authors: Yusuf Cetin
authors: YC
authors: Doganer
authors: David C
authors: DC
authors: Agerter
authors: Umit
authors: U
authors: Aydogan
authors: Cem
authors: C
authors: Barcin
mesh_terms: D002309:Cardiology; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000453:epidemiology; D003198:Computer Simulation; D017023:Coronary Angiography; D005080:Exercise Test; D005260:Female; D019983:Guideline Adherence; D006761:Hospitals; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D019984:Quality Indicators, Health Care; D012307:Risk Factors; D012955:Societies, Medical; D014421:Turkey / Q000453:epidemiology; D014481:United States
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors